RICHMOND, Va., May 19, 2020 /PRNewswire/ -- Phlow, a U.S.-based, public benefit drug manufacturing corporation, has received federal government funding of $354 million for advanced manufacturing of ...
Phlow Corp., a public benefit essential medicines solutions provider, and the United States Pharmacopeia (USP) today announced a strategic alliance to develop a new laboratory that will certify and ...
RICHMOND, Va., and MENLO PARK, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the ...
RICHMOND, Va.--(BUSINESS WIRE)--Today Phlow Corp. released the following statement on the introduction of S.2740, the Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves ...
RICHMOND, Va, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), congratulates Governor Glenn ...
Richmond-based Phlow Corp. has promoted Dan Hackman from chief business officer to president, the pharmaceutical manufacturing company announced Thursday. Hackman joined Phlow in 2020. He previously ...
Richmond, Virginia, March 17, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a U.S.-based certified B Corporation on a mission to bring medicines to life through advanced development and manufacturing in ...
RICHMOND, Va, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), today announced that the active ...
<a href="https://www.sec.gov/litigation/complaints/2023/comp-pr2023-38.pdf" target="_blank">A former Richmond pharmaceutical company executive</a> has been arrested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results